These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15793196)

  • 1. Renal status among patients using metformin in a primary care setting.
    Kennedy L; Herman WH;
    Diabetes Care; 2005 Apr; 28(4):922-4. PubMed ID: 15793196
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes: Metformin and renal insufficiency-is 45, or even 30, the new 60?
    Bloomgarden Z
    Nat Rev Endocrinol; 2015 Dec; 11(12):693-4. PubMed ID: 26416220
    [No Abstract]   [Full Text] [Related]  

  • 3. Prescribing of metformin based on estimated GFR rather than serum creatinine expands the eligible population and is likely safe.
    Castelino RL; Peterson G
    Evid Based Med; 2016 Apr; 21(2):68. PubMed ID: 26786825
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal function markers and metformin eligibility.
    Tavares Bello C; Castro Fonseca R; Sousa Santos F; Sequeira Duarte J; Azinheira J; Vasconcelos C
    Minerva Endocrinol; 2018 Sep; 43(3):246-252. PubMed ID: 28565889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine.
    Tuot DS; Lin F; Shlipak MG; Grubbs V; Hsu CY; Yee J; Shahinian V; Saran R; Saydah S; Williams DE; Powe NR;
    Diabetes Care; 2015 Nov; 38(11):2059-67. PubMed ID: 26307607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conference report: renal disease, metformin, and the adipocyte.
    Bloomgarden ZT
    Diabetes Care; 1996 Sep; 19(9):1038-41. PubMed ID: 8875112
    [No Abstract]   [Full Text] [Related]  

  • 7. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
    Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
    J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metformin is also recommended in mild and moderate renal failure].
    Zechmann S
    Praxis (Bern 1994); 2015 Mar; 104(7):370-1. PubMed ID: 25804780
    [No Abstract]   [Full Text] [Related]  

  • 9. [How I treat ... with metformin a diabetic patient with moderate renal insufficiency].
    Scheen AJ
    Rev Med Liege; 2013 Apr; 68(4):190-5. PubMed ID: 23755710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could metformin be used in patients with diabetes and advanced chronic kidney disease?
    Chowdhury TA; Srirathan D; Abraham G; Oei EL; Fan SL; McCafferty K; Yaqoob MM
    Diabetes Obes Metab; 2017 Feb; 19(2):156-161. PubMed ID: 27690331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study.
    Richy FF; Sabidó-Espin M; Guedes S; Corvino FA; Gottwald-Hostalek U
    Diabetes Care; 2014 Aug; 37(8):2291-5. PubMed ID: 24879835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin monitoring and change in serum creatinine levels in patients undergoing radiologic procedures involving administration of intravenous contrast media.
    Parra D; Legreid AM; Beckey NP; Reyes S
    Pharmacotherapy; 2004 Aug; 24(8):987-93. PubMed ID: 15338847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metformin and kidney].
    Sessa C; Blanco J; Granata A; Fatuzzo P; Castellino P; Zanoli L
    G Ital Nefrol; 2016; 33(3):. PubMed ID: 27374392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Metformin Use in Diabetic Kidney Disease.
    Kawanami D; Takashi Y; Tanabe M
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancies between the summary of characteristics and the recommended use of metformin in the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; López-Menchero R
    Nefrologia; 2012; 32(6):837-8; author reply 388-9. PubMed ID: 23169370
    [No Abstract]   [Full Text] [Related]  

  • 16. [Metformin is commonly used in patients with renal impairment].
    Alscher MD
    Dtsch Med Wochenschr; 2015 Nov; 140(22):1656. PubMed ID: 26536639
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948-955.
    Fu EL; van Diepen M
    Diabetes Care; 2020 Nov; 43(11):e190. PubMed ID: 33082247
    [No Abstract]   [Full Text] [Related]  

  • 18. Saxagliptin plus metformin combination in patients with type 2 diabetes and renal impairment.
    Scheen AJ
    Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):383-94. PubMed ID: 22313172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiabetics in chronic kidney disease: new questions to new and classical drugs.
    Serra-Tarragón J
    Nefrologia; 2012; 32(6):835; author reply 835-7. PubMed ID: 23169369
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948-955.
    Kwon S; Kim CT; Lee JP
    Diabetes Care; 2020 Nov; 43(11):e191. PubMed ID: 33082248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.